Form 4: Exelixis CEO Michael Morrissey Exercises Options, Gifts Shares to Trust
SEC Form 4 Filing
Exelixis CEO Michael Morrissey exercised stock options, resulting in the acquisition and disposal of shares, and gifted shares to a family trust.
Summary
- On October 1, 2024, Michael Morrissey, the President and CEO of Exelixis, exercised stock options to purchase 480,000 shares of common stock at a price of $24.41 per share.
- As a result of a 'net exercise', Morrissey received 16,298 shares of common stock, while 463,702 shares were withheld by Exelixis for payment of the exercise price and tax withholding, based on a closing stock price of $26.30 on October 1, 2024.
- On October 3, 2024, Morrissey gifted 16,298 shares of common stock to the Morrissey Family Trust.
- Following these transactions, Morrissey directly owns 964,384 shares of Exelixis common stock and indirectly owns 1,453,212 shares through a family trust and 17,728 shares through the Exelixis, Inc. 401(k) Plan.
- Morrissey also holds options representing the right to purchase 0 shares of Exelixis common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. The information is relevant to investors as it provides insight into management's perspective on the company's stock and their personal investment decisions.
Comparison to Industry Standards
- Insider transactions are a normal part of executive compensation at publicly traded companies like Exelixis.
- Similar transactions are regularly reported by executives at comparable biotech firms such as Gilead Sciences, Amgen, and Biogen.
- The reporting requirements and format of Form 4 filings are standardized across all companies listed on U.S. stock exchanges.
Related Party Transactions
- The gifting of shares to the Morrissey Family Trust constitutes a related party transaction.
Stakeholder Impact
- The transactions themselves have minimal direct impact on stakeholders.
- However, transparency in insider transactions is important for maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| July 21, 1994 | Date of the Morrissey Family Living Trust |
| October 3, 2018 | Original Expiration Date of Option (right to buy) |
| October 1, 2024 | Date of stock option exercise and net settlement. |
| October 1, 2024 | Date of plan statement for 401(k). |
| October 2, 2024 | Expiration Date of Option (right to buy) |
| October 3, 2024 | Date of gifting shares to the Morrissey Family Trust. |
| October 3, 2021 | Option became fully exercisable. |
| October 3, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.